Yi‐Ching Wang
- Cancer Research top 0.5%
- Molecular Biology top 1%
- Epigenetics and DNA Methylation 44
- RNA modifications and cancer 38
- Cancer-related gene regulation 27
- Ubiquitin and proteasome pathways 17
- Histone Deacetylase Inhibitors Research 15
- DNA Repair Mechanisms 12
- Oncology top 2%
- Cancer-related Molecular Pathways 24
- Structural Biology top 5%
-
- Autophagy in Disease and Therapy 11
- Co-authors
- Han‐Shui HsuJayu JenRuo-Kai LinYen-An TangChih‐Yi ChenWu‐Wei LaiRuo-Chia TsengJer-Wei Chang
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Yi‐Ching Wang
181 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Cancer Research 1.7k
- Molecular Biology 4.7k
- Oncology 1.5k
- Structural Biology 61
- Pulmonary and Respiratory Medicine 870
Countries citing papers authored by Yi‐Ching Wang
This map shows the geographic impact of Yi‐Ching Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi‐Ching Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi‐Ching Wang more than expected).
Fields of papers citing papers by Yi‐Ching Wang
This network shows the impact of papers produced by Yi‐Ching Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi‐Ching Wang. The network helps show where Yi‐Ching Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yi‐Ching Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 14 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 25 | |
| 8 | 2022 | 12 | |
| 9 | 2022 | 9 | |
| 10 | 2021 | 58 | |
| 11 | 2016 | 44 | |
| 12 | 2013 | 75 | |
| 13 | 2012 | 64 | |
| 14 | 2012 | 21 | |
| 15 | 2011 | 36 | |
| 16 | 2011 | 115 | |
| 17 | 2010 | 112 | |
| 18 | 2010 | 172 | |
| 19 | 2008 | 37 | |
| 20 | The trafgen traffic generator | 2002 | 1 |
About Yi‐Ching Wang
Yi‐Ching Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Immunology and Allergy, having authored 187 papers that have together received 6.9k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (44 papers), RNA modifications and cancer (38 papers), Cancer-related gene regulation (27 papers), Cancer-related Molecular Pathways (24 papers), Ubiquitin and proteasome pathways (17 papers), Histone Deacetylase Inhibitors Research (15 papers), DNA Repair Mechanisms (12 papers) and Autophagy in Disease and Therapy (11 papers). The work is most often cited by research in Cancer Research (1.7k citations), Molecular Biology (4.7k citations), Oncology (1.5k citations), Structural Biology (61 citations) and Pulmonary and Respiratory Medicine (870 citations). Yi‐Ching Wang has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Han‐Shui Hsu, Jayu Jen, Ruo-Kai Lin, Yen-An Tang, Chih‐Yi Chen, Wu‐Wei Lai, Ruo-Chia Tseng, Jer-Wei Chang, Pinpin Lin and Jung-Ta Chen. Their work appears in journals such as Journal of Biomedical Science, Lung Cancer, PLoS ONE, Clinical Cancer Research and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.